26 Comments
 

The lack of responses on the last post you made about this should tell you how generally difficult the move is.

I personally haven’t seen anyone do it, most RX groups usually only take laterals from folks that at top groups at an EB/BB on the unlikely chance that there are spots open. Maybe it’s possible at an Imperial or a GLC type firm? Personally I’ve not seen that happen yet either though. Might be better going for an RX consulting firm like an Alix or A&M for FT then try and lateral to an RX group if you’re really that passionate about it but I wouldn’t know.

 

That’s makes sense for the consulting thing. Figured I should ask on this kids behalf but would something like Jefferies or Baird RX might be possible from a MM role?

If he’s after exits they probably don’t exit nearly as well but if he’s genuinely interested in RX those aren’t bad places to get started and I think the low tier RX IB -> a good group like a Gugg/Ducera/PWP or even top group you mentioned would certainly be POSSIBLE as an associate or something 

 

Wouldn’t say those firms are low-tier. You’d have to have a good reason for Rx. These groups like to take people who are interested in the topic. Not people who are worried the market is bad and want good deal flow.

 

You can tell this kid has no idea what he’s talking about comparing Jeff RX to Baird 💀

 

rx guys are extremely passionate about rx which is good, obviously they get really good at it. For me if someone wants to let me in I would do rx but I wont spend time reading about it often bc it just doesn't make sense to. its cool though and something I definitely would have looked into if I was raised in nj/ct.

I think if your truly passionate about rx you will get in obviously people are pretty receptive to people with common interests/passions. I am rooting for you to lateral! 

 

I don’t think it’s impossible, but it’s difficult. I’ve seen laterals from BB to tier 1 Rx firms, and also laterals from tier 2 to tier 1 RX shops. I think the difficulty in lateraling arises not only from how technically challenging the work is, but also from how few spots in here are in RX compared to M&A and coverage groups.

 

In sunt quo pariatur ut. Ipsam dolorem expedita nemo quaerat. Neque voluptas culpa sed adipisci saepe perspiciatis nihil.

Qui magni tempora dolorem expedita doloremque. Aut est sint ea est quia est incidunt. Odit ut ipsa saepe corrupti dolorem dolorem aliquam. Deleniti deserunt ut deleniti.

Inventore laudantium quod voluptas. Dolorum ut aut et error officiis in et. Qui praesentium assumenda laudantium sunt et fugit voluptas. Est deserunt et repellendus non.

Career Advancement Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • JPMorgan 01 98.4%
  • Guggenheim Partners 02 97.9%
  • Morgan Stanley 06 97.4%

Overall Employee Satisfaction

November 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 99.0%
  • Evercore 01 98.4%
  • Banco Santander 02 97.9%
  • BMO Capital Markets 13 97.4%

Professional Growth Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

November 2026 Investment Banking

  • Vice President (16) $429
  • Associates (57) $264
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (29) $183
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (76) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”